PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportssleep initiation and maintenance disorders
MeSH D007319 - sleep initiation and maintenance disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D020919:Intrinsic sleep disorders
0 Companies
0 Drugs
Success rate
D007319: 
Sleep initiation and maintenance disorders
D034062:Fatal familial insomnia
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyDiphenhydramine Diphenhydramine  1982-01-01   
Abbott BiotherapeuticsEstazolam Prosom  1990-12-26   
Accord HealthcareTrazodone Trazodone  2017-09-08   
ACME LaboratoriesZolpidem Zolpidem  2007-04-23   
Alembic PharmaceuticalsTemazepam Temazepam  2018-11-23   
Alkem LaboratoriesTemazepam Temazepam  2023-08-24   
AllerganDiphenhydramine Diphenhydramine  1982-01-01   
Doxylamine, Pyridoxine Doxylamine Pyridoxine  2016-08-19   
Estazolam Estazolam  1997-08-19   
Lorazepam Lorazepam  1987-03-23   
Ramelteon Ramelteon  2015-08-19   
Temazepam Temazepam  1987-03-23   
Trazodone Trazodone  1986-10-10   
Zolpidem Zolpidem  2007-04-23   
Almatica PharmaLorazepam Loreev 2034-01-08 2021-08-27   
Zolpidem Zolpidem  2023-05-09   
AlpharmaCodeine, BROMODIPHENHYDRAMINE Bromanyl  1984-08-15   
Diphenhydramine Diphenhydramine  1989-04-25   
Diphenhydramine Hydramine  1986-01-28   
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
74%
17/23
Phase 2
57%
16/28
Phase 3
68%
40/59
Approved: 25Overall Success rate: 29%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use